BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19609069)

  • 1. Tanshinone IIA selectively enhances hyperpolarization-activated cyclic nucleotide-modulated (HCN) channel instantaneous current.
    Liang Q; Yang L; Wang Z; Huang S; Li S; Yang G
    J Pharmacol Sci; 2009 Jul; 110(3):381-8. PubMed ID: 19609069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tanshinone IIA: a new activator of human cardiac KCNQ1/KCNE1 (I(Ks)) potassium channels.
    Sun DD; Wang HC; Wang XB; Luo Y; Jin ZX; Li ZC; Li GR; Dong MQ
    Eur J Pharmacol; 2008 Aug; 590(1-3):317-21. PubMed ID: 18573250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A leucine zipper motif essential for gating of hyperpolarization-activated channels.
    Wemhöner K; Silbernagel N; Marzian S; Netter MF; Rinné S; Stansfeld PJ; Decher N
    J Biol Chem; 2012 Nov; 287(48):40150-60. PubMed ID: 23048023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of hyperpolarization-activated pacemaker current defined by coassembly of HCN1 and HCN2 subunits and basal modulation by cyclic nucleotide.
    Chen S; Wang J; Siegelbaum SA
    J Gen Physiol; 2001 May; 117(5):491-504. PubMed ID: 11331358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro characterization of HCN channel kinetics and frequency dependence in myocytes predicts biological pacemaker functionality.
    Zhao X; Bucchi A; Oren RV; Kryukova Y; Dun W; Clancy CE; Robinson RB
    J Physiol; 2009 Apr; 587(Pt 7):1513-25. PubMed ID: 19171659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local anesthetic inhibits hyperpolarization-activated cationic currents.
    Meng QT; Xia ZY; Liu J; Bayliss DA; Chen X
    Mol Pharmacol; 2011 May; 79(5):866-73. PubMed ID: 21303986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular Mg2+ is a voltage-dependent pore blocker of HCN channels.
    Vemana S; Pandey S; Larsson HP
    Am J Physiol Cell Physiol; 2008 Aug; 295(2):C557-65. PubMed ID: 18579800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-equilibrium behavior of HCN channels: insights into the role of HCN channels in native and engineered pacemakers.
    Azene EM; Xue T; Marbán E; Tomaselli GF; Li RA
    Cardiovasc Res; 2005 Aug; 67(2):263-73. PubMed ID: 16005302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode shifts in the voltage gating of the mouse and human HCN2 and HCN4 channels.
    Elinder F; Männikkö R; Pandey S; Larsson HP
    J Physiol; 2006 Sep; 575(Pt 2):417-31. PubMed ID: 16777944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voltage sensor movement and cAMP binding allosterically regulate an inherently voltage-independent closed-open transition in HCN channels.
    Chen S; Wang J; Zhou L; George MS; Siegelbaum SA
    J Gen Physiol; 2007 Feb; 129(2):175-88. PubMed ID: 17261842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of hyperpolarization-activated HCN channel gating and cAMP modulation due to interactions of COOH terminus and core transmembrane regions.
    Wang J; Chen S; Siegelbaum SA
    J Gen Physiol; 2001 Sep; 118(3):237-50. PubMed ID: 11524455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct evidence for calcium conductance of hyperpolarization-activated cyclic nucleotide-gated channels and human native If at physiological calcium concentrations.
    Michels G; Brandt MC; Zagidullin N; Khan IF; Larbig R; van Aaken S; Wippermann J; Hoppe UC
    Cardiovasc Res; 2008 Jun; 78(3):466-75. PubMed ID: 18252758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of cyclic nucleotide-regulated HCN channels by PIP(2) and receptors coupled to phospholipase C.
    Pian P; Bucchi A; Decostanzo A; Robinson RB; Siegelbaum SA
    Pflugers Arch; 2007 Oct; 455(1):125-45. PubMed ID: 17605039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation gating in HCN2 channels.
    Hummert S; Thon S; Eick T; Schmauder R; Schulz E; Benndorf K
    PLoS Comput Biol; 2018 Mar; 14(3):e1006045. PubMed ID: 29565972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voltage-dependent opening of HCN channels: Facilitation or inhibition by the phytoestrogen, genistein, is determined by the activation status of the cyclic nucleotide gating ring.
    Rozario AO; Turbendian HK; Fogle KJ; Olivier NB; Tibbs GR
    Biochim Biophys Acta; 2009 Sep; 1788(9):1939-49. PubMed ID: 19524546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional determinants in the S5-P region of HCN-encoded pacemaker channels revealed by cysteine-scanning substitutions.
    Au KW; Siu CW; Lau CP; Tse HF; Li RA
    Am J Physiol Cell Physiol; 2008 Jan; 294(1):C136-44. PubMed ID: 17989208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S4 movement in a mammalian HCN channel.
    Vemana S; Pandey S; Larsson HP
    J Gen Physiol; 2004 Jan; 123(1):21-32. PubMed ID: 14676284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Niflumic acid alters gating of HCN2 pacemaker channels by interaction with the outer region of S4 voltage sensing domains.
    Cheng L; Sanguinetti MC
    Mol Pharmacol; 2009 May; 75(5):1210-21. PubMed ID: 19218366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hysteresis in the voltage dependence of HCN channels: conversion between two modes affects pacemaker properties.
    Männikkö R; Pandey S; Larsson HP; Elinder F
    J Gen Physiol; 2005 Mar; 125(3):305-26. PubMed ID: 15710913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine kinase inhibition differentially regulates heterologously expressed HCN channels.
    Yu HG; Lu Z; Pan Z; Cohen IS
    Pflugers Arch; 2004 Jan; 447(4):392-400. PubMed ID: 14634823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.